Cyclic nucleotide-gated channel alpha-2

BE0014924ProteinHumansCNGA2

Pore-forming subunit of the olfactory cyclic nucleotide-gated channel. It is acted on by 1 drug in DrugBank.

Gene name: CNGA2
UniProtKB entry: Q16280Swiss-Prot
Cellular location: Cell projection, cilium membrane
Residues / weight: 664 residues · 76,048 Da
Also known as: CNCA · CNCA1 · CNCG2 · CNG channel alpha-2 · CNG-2

Resolves to

Protein

UniProtQ16280UniProt nameCNGA2_HUMAN

Gene

HGNCHGNC:2149NCBI Gene1260GeneCardsCNGA2

Pharmacology

IUPHAR/GtoPdb395KEGGhsa:1260

Structure

PDB9UPFPDB9UPG

Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action

14GO termsFunction, process and component, as structured annotations

3Pfam domainsDomain architecture mapped to Pfam families and clans

1+ReferenceStructured and connected to the statements they support

Which approved drugs act on Cyclic nucleotide-gated channel alpha-2, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account